Search results
Results from the WOW.Com Content Network
On April 29, 2013, Bayer AG made a cash offer of $31.00 per share for Conceptus, a 20% premium to the company's stock market price, valuing it at $1.1bn. [2] The deal was completed and closed on June 5, 2013.
The Center for Research in Security Prices, LLC (CRSP) is a provider of historical stock market and investable index data. CRSP is an affiliate of the Booth School of Business at the University of Chicago. CRSP maintains some of the largest and most comprehensive proprietary historical databases in stock market research.
Alamy By Ludwig Burger FRANKFURT -- Germany's Bayer has agreed to buy U.S. contraceptive devices maker Conceptus for $1.1 billion, aiming to underpin its position as the world's largest women's ...
At this writing, the stock trades at a price-to-earnings ratio (P/E) of 26, which is below the S&P 500 (SNPINDEX: ^GSPC) and Nasdaq Composite averages of more than 30.
Conceptus INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Conceptus, Inc. Following Announcement of Proposed Sale of Company to Bayer HealthCare ...
C. C-COR; CA Technologies; CafePress; Calamos Investments; CalAmp; California Pizza Kitchen; CallidusCloud; Calyx (clinical research company) Cambium Learning Group
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us